Hydroxocobalamin and Disseminated intravascular coagulation - a phase IV clinical study of FDA data

Summary:

Disseminated intravascular coagulation is reported as a side effect among people who take Hydroxocobalamin (hydroxocobalamin), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Alimta, and have Constipation.

The phase IV clinical study analyzes which people have Disseminated intravascular coagulation when taking Hydroxocobalamin. It is created by eHealthMe based on reports of 4,242 people who have side effects when taking Hydroxocobalamin from the FDA, and is updated regularly.

What is Hydroxocobalamin?

Hydroxocobalamin has active ingredients of hydroxocobalamin. It is often used in pernicious anaemia. eHealthMe is studying from 4,273 Hydroxocobalamin users. Check the latest studies of Hydroxocobalamin.

What is Disseminated intravascular coagulation?

Disseminated intravascular coagulation (systemic activation of blood coagulation) is found to be associated with 1,168 drugs and 1,771 conditions by eHealthMe. Check the latest studies of Disseminated intravascular coagulation.

On Jul, 30, 2026

4,242 people reported to have side effects when taking Hydroxocobalamin.
Among them, 20 people (0.47%) have Disseminated intravascular coagulation.

Could Hydroxocobalamin cause Disseminated intravascular coagulation?

Among these 20 people:

How long have people been on Hydroxocobalamin when they have Disseminated intravascular coagulation? *

What is the gender of people who have Disseminated intravascular coagulation when taking Hydroxocobalamin? *

female: 40 %
male: 60 %

What is the age of people who have Disseminated intravascular coagulation when taking Hydroxocobalamin? *

What are other drugs people take besides Hydroxocobalamin? *

Alimta: 9 people, 45.00%
Cisplatin: 8 people, 40.00%
Pemetrexed: 7 people, 35.00%
Oxycontin: 5 people, 25.00%
Warfarin Sodium: 4 people, 20.00%
Sulfamethoxazole: 4 people, 20.00%
Avastin: 4 people, 20.00%
Dexamethasone Sodium Phosphate: 4 people, 20.00%
Fragmin: 3 people, 15.00%
Furosemide: 3 people, 15.00%

What are other side effects people have besides Disseminated intravascular coagulation? *

Thrombocytopenia (decrease of platelets in blood): 9 people, 45.00%
Interstitial Lung Disease: 8 people, 40.00%
Anaemia (lack of blood): 7 people, 35.00%
White Blood Cell Count Decreased: 4 people, 20.00%
Malignant Neoplasm Progression (cancer tumour came back): 4 people, 20.00%
Alanine Aminotransferase Increased: 4 people, 20.00%
Aspartate Aminotransferase Increased: 4 people, 20.00%
Colitis (inflammation of colon): 4 people, 20.00%
Lower Gastrointestinal Haemorrhage (bleeding in the large intestine, rectum, or anus is called lower gi bleeding): 4 people, 20.00%
Febrile Neutropenia (fever with reduced white blood cells): 4 people, 20.00%

What are the existing conditions these people have? *

Constipation: 6 people, 30.00%
Cancer Pain: 5 people, 25.00%
Lung Adenocarcinoma Stage Iv (the cancer has spread to other organs of the body, such as the other lung, brain, or liver): 5 people, 25.00%
Tumor Associated Fever: 4 people, 20.00%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 4 people, 20.00%
Pleural Mesothelioma Malignant (cancer of the pleura, or the membrane that lines the lungs): 4 people, 20.00%
Dermatitis Exfoliative Generalised (inflammatory skin disease with erythema and scaling that affects nearly the entire cutaneous surface): 4 people, 20.00%
Lung Carcinoma Cell Type Unspecified Stage Iv (the lung cancer has spread to other organs of the body, such as the other lung, brain, or liver): 4 people, 20.00%
Gastric Ulcer (stomach ulcer): 4 people, 20.00%
Insomnia (sleeplessness): 3 people, 15.00%

* Approximation only. Some reports may have incomplete information.

Do you take Hydroxocobalamin and have Disseminated intravascular coagulation?

- Check whether Disseminated intravascular coagulation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Hydroxocobalamin:

Hydroxocobalamin (4,273 reports)

Disseminated intravascular coagulation treatments and more:

Disseminated intravascular coagulation (24,199 reports)

How severe was Disseminated intravascular coagulation and when was it recovered:

Disseminated intravascular coagulation in Hydroxocobalamin

Expand to all the drugs that have ingredients of hydroxocobalamin:

Disseminated intravascular coagulation and drugs with ingredients of hydroxocobalamin

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Hydroxocobalamin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Disseminated intravascular coagulation:

Disseminated intravascular coagulation (1,168 drugs)

Browse all the conditions that are associated with Disseminated intravascular coagulation:

Disseminated intravascular coagulation (1,771 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on hydroxocobalamin (the active ingredients of Hydroxocobalamin) and Hydroxocobalamin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.